ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,163Medicare Part D Prescriptions Filled, Including Refills

Rank: 118 out of 917

$518K Total Retail Price of All Prescriptions

Rank: 106 out of 917

535 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
32% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Washington
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 535 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

8% of this provider’s 535 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

4% of this provider’s 7,798 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$57 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Washington
SIMVASTATIN 514 419 1 2
LISINOPRIL 434 370 2 1
LEVOTHYROXINE SODIUM 376 354 3 3
OMEPRAZOLE 334 298 4 4
ATORVASTATIN CALCIUM 290 261 5 14
WARFARIN SODIUM 256 225 6 10
HYDROCHLOROTHIAZIDE 218 207 7 9
METFORMIN HCL 200 182 8 8
AMLODIPINE BESYLATE 198 184 9 5
FUROSEMIDE 188 170 10 7
ATENOLOL 185 163 11 12
LOSARTAN POTASSIUM 179 174 12 13
CITALOPRAM HBR 172 159 13 15
METOPROLOL TARTRATE 153 118 14 11
MELOXICAM 133 104 15 53
HYDROCODONE-ACETAMINOPHEN 117 105 S3 16 6
PANTOPRAZOLE SODIUM 109 100 17 44
LISINOPRIL-HYDROCHLOROTHIAZIDE 109 98 17 42
JANUVIA 101 93 19 81
SPIRIVA 101 69 19 45
GABAPENTIN 97 61 21 17
POTASSIUM CHLORIDE 93 89 22 16
PROAIR HFA 91 77 23 35
METOPROLOL SUCCINATE 89 87 24 18
ALLOPURINOL 87 72 25 31
SERTRALINE HCL 82 74 26 24
LOVASTATIN 82 58 26 19
CRESTOR 79 62 28 30
GLYBURIDE 78 72 R 29 71
TAMSULOSIN HCL 77 74 30 25
ZOLPIDEM TARTRATE 62 58 31 21
DIGOXIN 61 28 32 41
DICLOFENAC SODIUM 58 57 33 117
KLOR-CON 10 57 34 34 115
NAMENDA 56 56 35 43
FENOFIBRATE 54 54 36 73
LUNESTA 52 42 37 384
AZITHROMYCIN 52 43 37 61
VENLAFAXINE HCL ER 51 49 39 78
AMITRIPTYLINE HCL 51 36 R 39 67
FLUTICASONE PROPIONATE 50 48 41 26
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 17, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.